| ADR Ontology |
| ADR Term |
Post concussion syndrome |
| ADR ID |
BADD_A08295 |
| ADR Hierarchy |
|
| Description |
The organic and psychogenic disturbances observed after closed head injuries (HEAD INJURIES, CLOSED). Post-concussion syndrome includes subjective physical complaints (i.e. headache, dizziness), cognitive, emotional, and behavioral changes. These disturbances can be chronic, permanent, or late emerging. [MeSH] |
| MedDRA Code |
10057230 |
| MeSH ID |
D038223; D000070627; D038223
|
|
ADR Severity Grade (FAERS)
|
|
|
ADR Severity Grade (CTCAE)
|
Not Available
|
| Synonym |
| Post-traumatic brain syndrome | Postconcussion syndrome | Postconcussional syndrome | Post-traumatic syndrome | Post concussion syndrome | Post-traumatic encephalopathy | Post-Concussion Syndrome | Post Concussion Syndrome | Post-Concussive Symptoms | Post Concussive Symptoms | Post-Concussive Symptom | Post-Concussion Symptoms | Post Concussion Symptoms | Post-Concussion Symptom | Post-Concussive Syndrome | Post Concussive Syndrome | Post-Concussive Syndromes | Post-Concussive Syndrome, Chronic | Chronic Post-Concussive Syndrome | Chronic Post-Concussive Syndromes | Post Concussive Syndrome, Chronic | Post-Concussive Syndromes, Chronic |
|
|
| ADR Related Proteins |
| Protein Name |
UniProt AC |
TTD Target ID |
| Not Available | Not Available | Not Available |
|
| Drugs Leading to the ADR |
| Drug ID | Drug Name | ADR Frequency (FAERS) | ADR Severity Grade (FAERS) | | BADD_D00066 | Alendronic acid | 0.000202% | | | BADD_D00100 | Ambrisentan | 0.000577% | |
| The 1th Page 1
Total 1 Pages
|
|
